Marshall Edwards initiates trial of chemo-sensitizer
The investigator-initiated clinical study will take place at the Yale University School of Medicine and will enroll 60 women with recurrent epithelial ovarian, fallopian tube or abdominal cavity
Teva Pharmaceuticals International has made a bid to acquire a range of neuroscience assets from BioXcel Therapeutics for a total deal value of $125m.